Our attorneys have filed a mass tort lawsuit on behalf of individuals who took the blood thinner Xarelto (rivaroxaban) and suffered serious bleeding events. Pharmaceutical businesses, including the makers of Xarelto, have a duty to ensure that their drugs are reasonably protected for use - and failure to perform so may be grounds for compensation. Our lawyers are operating challenging to obtain those hurt by the drug the compensation they may be entitled to.

Even though bleeding is really a frequent complication connected with anticoagulants, it has been alleged that Xarelto is much more unsafe than conventional blood thinners because no antidote exists to reverse its blood-thinning effects. This indicates that, in the event of an emergency, patients might be at threat for irreversible bleeding problems, such as life-threatening internal and gastrointestinal hemorrhaging.

In case you or perhaps a loved one suffered a critical bleeding event soon after taking Xarelto, you may have legal recourse. For a lot more info, make contact with us right now to have your case reviewed, free of charge.
Compensation Possibilities

xarelto-compensation-photoThe plaintiffs in these lawsuits are searching for compensation from Bayer and Janssen for previous and future health-related bills, lost wages, discomfort and suffering and, in instances of death, funeral expenses. Moreover, they are seeking punitive damages, that are typically awarded to punish the defendant and deter other firms from acting similarly.
Why Are Lawsuits Becoming Filed?

Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several does xarelto have a reversal agent lawsuits alleging that the drug is dangerous and defective. The plaintiffs claim that, unlike classic anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Due to the fact of this, the lawsuits claim, doctors have no effective implies of stopping Xarelto users from bleeding within the occasion of an emergency. Plaintiffs within the lawsuits allege critical and fatal injuries, such as cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.

In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:

The manufacturers of Xarelto marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a safe anticoagulant option.
Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user in the event of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.
Xarelto is linked to significant bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing hazardous clotting.

Visit this page for far more information on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set

The attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.
이 게시물을..